Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.
Wirden M, Delaugerre C, Marcelin AG, Ktorza N, Ait Mohand H, Dominguez S, Schneider L, Ghosn J, Pauchard M, Costagliola D, Katlama C, Calvez V. Wirden M, et al. Among authors: dominguez s. Antimicrob Agents Chemother. 2004 Feb;48(2):644-7. doi: 10.1128/AAC.48.2.644-647.2004. Antimicrob Agents Chemother. 2004. PMID: 14742228 Free PMC article. Clinical Trial.
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.
Wirden M, Marcelin AG, Tubiana R, Valantin MA, Ghosn J, Duvivier C, Dominguez S, Paris L, Agher R, Peytavin G, Katlama C, Calvez V. Wirden M, et al. Among authors: dominguez s. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):876-8. doi: 10.1097/00126334-200407010-00016. J Acquir Immune Defic Syndr. 2004. PMID: 15213573 No abstract available.
Acute hepatitis C in HIV-infected men who have sex with men.
Ghosn J, Pierre-François S, Thibault V, Duvivier C, Tubiana R, Simon A, Valantin MA, Dominguez S, Caumes E, Katlama C. Ghosn J, et al. Among authors: dominguez s. HIV Med. 2004 Jul;5(4):303-6. doi: 10.1111/j.1468-1293.2004.00225.x. HIV Med. 2004. PMID: 15236621 Free article.
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Delaugerre C, Peytavin G, Dominguez S, Marcelin AG, Duvivier C, Gourlain K, Amellal B, Legrand M, Raffi F, Costagliola D, Katlama C, Calvez V. Delaugerre C, et al. Among authors: dominguez s. J Med Virol. 2005 Nov;77(3):345-50. doi: 10.1002/jmv.20462. J Med Virol. 2005. PMID: 16173015 Clinical Trial.
Skin rash associated with atazanavir: report of three cases.
Ouagari Z, Tubiana R, Mohand HA, Dominguez S, Duvivier C, Bricaire F, Katlama C, Caumes E. Ouagari Z, et al. Among authors: dominguez s. AIDS. 2006 May 12;20(8):1207-8. doi: 10.1097/01.aids.0000226965.17966.3c. AIDS. 2006. PMID: 16691076 No abstract available.
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients.
Wirden M, Roquebert B, Derache A, Simon A, Duvivier C, Ghosn J, Dominguez S, Boutonnet V, Ait-Arkoub Z, Katlama C, Calvez V, Marcelin AG. Wirden M, et al. Among authors: dominguez s. Antimicrob Agents Chemother. 2006 Jul;50(7):2553-6. doi: 10.1128/AAC.00092-06. Antimicrob Agents Chemother. 2006. PMID: 16801444 Free PMC article.
577 results